Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2 in Human Immunodeficiency Virus (HIV)

NCT03346499 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT03346499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03346499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2 in Human Immunodeficiency Virus (HIV)
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Completed
Start date
March 9, 2017
Completion date
November 13, 2018
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv